Uncover key drivers, emerging technologies, and competitive movements shaping the connected drug delivery devices market from 2025–2034 with trusted insights from The Business Research Company
What Is The Present Size Of The Connected Drug Delivery Devices Market And What Value Is Projected For 2029?
The connected drug delivery devices market has experienced significant expansion in recent years. Projections indicate it will expand from $7.48 billion in 2024 to $9.27 billion in 2025, achieving a compound annual growth rate (CAGR) of 23.9%. This historical growth stems from factors such as a rise in awareness regarding connected devices, the heightened importance of remote monitoring for medication adherence, greater patient engagement, broad consumer uptake, and the swiftly rising costs of medical management.
The connected drug delivery devices market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $21.81 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 23.9%. This expansion during the forecast period is driven by several factors, including the increasing prevalence of chronic diseases, heightened patient awareness regarding adherence to prescribed therapies, the rapid evolution of healthcare IT infrastructure, a stronger emphasis on preventive care, and the widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR). Furthermore, major trends in this period will involve increasing R&D activities, a surge in technological innovation and the increasing connectivity of devices, the accelerating adoption of machine learning and artificial intelligence, the rising implementation of telehealth platforms integrated with AR/VR technologies, and the growing incorporation of electronic technology in healthcare devices.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
What Factors Are Boosting The Connected Drug Delivery Devices Market?
The increasing significance of remote patient monitoring is projected to propel the expansion of the connected drug delivery device market moving forward. Remote patient monitoring (RPM) is a healthcare delivery method that leverages technology to monitor patient health and medical data remotely. Connected drug delivery devices enhance RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, in August 2023, a survey by Vivalink Inc., a US-based digital health solutions provider, indicated a 305% rise in clinicians utilizing remote patient monitoring (RPM) on patients, climbing from 20% in 2021 to 81% currently, with 84% of these users planning to extend their RPM usage in 2024. Thus, the growing importance of remote patient monitoring is fueling the growth of the connected drug delivery device market.
What Are The Core Segmentation Criteria In The Connected Drug Delivery Devices Market?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
Which Emerging Trends Are Reshaping The Connected Drug Delivery Devices Market Landscape?
Major companies operating in the connected drug delivery devices market are concentrating on developing innovative technology, such as digital respiratory health solutions, to boost their profitability in the market. A digital respiratory health solution for connected drug delivery devices refers to a technology-enabled instrument that facilitates medication administration to the respiratory system while tracking usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, unveiled HeroTracker Sense. This is an innovative digital tool designed to transform traditional metered-dose inhalers into smart, connected devices, thereby enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma, COPD, and others. It offers features such as sensors for analytics and insight, and it supports patient adherence monitoring via the BreatheSmart app, assisting in the effective management of respiratory diseases.
Which Players Are Shaping The Competitive Landscape Of The Connected Drug Delivery DevicesXX Market?
Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.
Download The Full Report Here:
What Regional Trends Are Shaping Growth In The Connected Drug Delivery Devices Market?
North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp
Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2025, By The Business Research Company
Interventional Cardiology Devices And Equipment Global Market Report 2025
Interventional Neurology Devices And Equipment Global Market Report 2025
Lancing Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model